Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the ...
1don MSN
Proton therapy shows survival benefit in phase III trial for patients with head and neck cancers
A study published in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who were ...
Patients with oropharyngeal carcinoma who receive proton therapy are more likely to develop this potentially debilitating complication than those who receive IMRT, a new study finds.
News-Medical.Net on MSN
Proton therapy improves survival in oropharyngeal cancer patients
A new study published today in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who ...
Of the 300 patients in the PARCER trial, 93 faced grades ≥2 adverse events (3D-CRT = 59, IG-IMRT = 34). Patients in the 3D-CRT and IG-IMRT arms spent an average of 2.39 years and 1.96 years in ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Please provide your email address to receive an email when new articles are posted on . Men with low- or intermediate-risk prostate cancer achieved similar quality-of-life outcomes whether they ...
Photon therapy offers strong outcomes in treating oropharyngeal cancers; however, some radiation can reach and damage nearby ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback